Neurology Book



Aka: Primidone, Mysoline
  1. Indications
    1. Seizure Disorder
      1. Grand Mal Seizure
      2. Psychomotor Seizure
      3. Focal Seizure
    2. Essential Tremor
  2. Contraindications
    1. Porphyria
    2. Phenobarbital Hypersensitivity
  3. Mechanism
    1. Barbiturate with 2 active metabolites
      1. Phenobarbital
      2. Phenylethylmalonamide (PEMA)
    2. Raises Seizure threshold
  4. Dosing: adults and children over age 8 years
    1. Titration to maintenance dose
      1. Days 1 to 3: Take 100-125 mg PO qhs
      2. Days 4 to 6: Take 100-125 mg PO bid
      3. Days 7 to 9: Take 100-125 mg PO tid
      4. Days >10: Take 250 mg PO tid
    2. Maintenance dosing
      1. Standard dosing: 250 mg PO tid-qid
      2. Maximum dosing: 500 mg PO qid (do not exceed)
  5. Monitoring: Labs every 6 months
    1. Complete Blood Count
    2. Chemistry panel (SMA-12)
  6. Adverse effects
    1. Common
      1. Ataxia
      2. Vertigo
    2. Occasional
      1. Nausea, Vomiting or Anorexia
      2. Fatigue or drowsiness
      3. Hyperirritability or other emotional disturbance
      4. Sexual Impotence
      5. Diplopia or Nystagmus
      6. Morbilliform skin rash
    3. Rare
      1. Megaloblastic Anemia responsive to Folate
Medication Costs
primidone (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
PRIMIDONE 250 MG TABLET Generic $0.15 each
PRIMIDONE 50 MG TABLET Generic $0.08 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Primidone (C0033148)

Definition (NCI) An analog of phenobarbital with antiepileptic property. Although the mechanism of action has not been fully elucidated, primidone probably exerts its actions, in a manner similar to phenobarbital, via activation of gamma-aminobutyric acid (GABA)-A receptor/chloride ionophore complex, which leads to prolonged and increased frequency of opening of the chloride channel within the receptor complex. This results in an alteration in the electrical activity of the nerve cell membrane, causing hyperpolarization and prevention of partial and tonic-clonic seizures. In addition, this agent is partially metabolized to phenobarbital and phenylethylmalonamide (PEMA), which may also contribute to its anti-seizure properties.
Definition (MSH) An antiepileptic agent related to the barbiturates; it is partly metabolized to PHENOBARBITAL in the body and owes some of its actions to this metabolite. Adverse effects are reported to be more frequent than with PHENOBARBITAL. (From Martindale, The Extra Pharmacopoeia, 30th ed, p309)
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D011324
SnomedCT 371193009, 387256009, 47120002
LNC LP14730-3, MTHU003369
English Primidone, Desoxyphenobarbital, Misodine, 4,6(1H,5H)-Pyrimidinedione, 5-ethyldihydro-5-phenyl-, 2-Deoxyphenobarbital, Mysedon, primidone, PRIMIDONE, primidone (medication), Primidone [Chemical/Ingredient], Primidone product (product), Primidone product, Hexamidinum, Primidone (product), Primidone (substance)
Swedish Primidon
Czech primidon
Finnish Primidoni
Japanese プリマクロン, デスオキシフェノバルビタール, プリミドン
Polish Prymidon, Mizodin
Spanish primidona, producto, primidona, producto (producto), desoxifenobarbital, primidona (producto), primidona (sustancia), primidona, Primidona, Desoxifenobarbital
French Désoxyphenobarbitone, Primaclone, Primidone
German Desoxyphenobarbital, Primidon
Italian Primidone
Portuguese Desoxifenobarbital, Primidona
Derived from the NIH UMLS (Unified Medical Language System)

Mysoline (C0700016)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D011324
English mysoline, Mysoline, Astra Brand of Primidone, AstraZeneca Brand of Primidone, Draxis Brand of Primidone, Mylepsinum, Xcel Brand of Primidone, Zeneca Brand of Primidone
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree